NCT01664234 is a NA clinical trial of laryngoscopy with oxygen in Infants, sponsored by Medical University of Vienna.

Who is sponsoring NCT01664234?

NCT01664234 is sponsored by Medical University of Vienna.

What drugs are being tested in NCT01664234?

Interventions in NCT01664234: laryngoscopy with oxygen, laryngoscopy without oxygen.

What condition does NCT01664234 study?

NCT01664234 studies Infants, Difficult Airway.

Is NCT01664234 still recruiting?

NCT01664234 is currently completed. Last updated 31 August 2023.

Last reviewed 2023-08-31 · How we verify

NCT01664234

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Oxygen Insuflation and ArterialDesaturation During Tracheal Intubation in Children

Completed NA Last updated 31 August 2023

What this trial tests

NA trial testing laryngoscopy with oxygen in Infants in 48 participants. Completed in 30 December 2014.

Timeline

1 January 2012

Primary endpoint
30 December 2014

30 December 2014

Quick facts

Lead sponsor	Medical University of Vienna
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	48
Start date	1 January 2012
Primary completion	30 December 2014
Estimated completion	30 December 2014
Sites	1 location across Austria

Drugs / interventions tested

laryngoscopy with oxygen
laryngoscopy without oxygen

Conditions studied

Infants — all drugs for Infants →
Difficult Airway — all drugs for Difficult Airway →

Sponsor

Medical University of Vienna

Who can join

Adults 1 Month to 2, any sex, with Infants or Difficult Airway. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Infants (0-1 yr.) with anticipated difficult airways will be enrolled in the study. Specifically, we will include infants with cleft palate, Pierre Robin, Treacher Collins, trisomy 21, or similar congenital malformations. Patients with American Society of Anesthesiologists physical status scores ≥3 will be excluded, as will those with congenital heart disease and left-to-right shunting. Patients will be randomly assigned to laryngoscopy with or without simultaneous insufflation of oxygen at 4 L/minute. Oxygen will be provided by a flowmeter connected via rigid tubing to the track-mounted endotracheal tube on the AirTraq. Randomization (1:1) will be based on computer-generated codes with random block sizes and stratified by hospital; allocation will be concealed and provided to clinicians via a secure web site that will be accessed shortly before induction of anesthesia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Infants

Currently open trials in the same condition.

NCT06319079 — Effect of Consumption of a Milk Product Designed for Lactating Women on Human Milk Composition · NA · recruiting
NCT05705258 — A Study to Collect Data on the Use of Eylea in Babies Born Too Early Who Have a Condition of the Eye Where Blood Vessels · recruiting
NCT06318858 — Daily and Weekly Iron Supplementation in Infants · NA · recruiting

Other Medical University of Vienna trials

Trials by the same sponsor.

NCT07473401 — Retinal Oxygen Metabolism in Children With Myopia · not yet recruiting
NCT07511400 — The Role of NaV1.8 in Human Pain Models · EARLY_PHASE1 · not yet recruiting
NCT07516990 — Intramuscular Injection of Mashed Parathyroid Tissue Into a Forearm During Thyroid Surgery to Prevent Permanent Postoper · NA · recruiting
NCT07496437 — Is Cross-linked Hyaluronic Acid a Biologic Alternative for Alveolar Ridge Preservation? · NA · not yet recruiting
NCT07290712 — Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01664234 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Vienna
Last refreshed: 31 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01664234.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing